Cabergoline and dyspnoea exertional Patient Reports February 12, 2012

Cabergoline Side Effects Report #4680723-X
Cabergoline side effect was reported by a Physician from on May 19, 2005. Female patient, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea exertional, endocarditis , fatigue, hyperkinesia, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with RESTEX, MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4650054-2
Cabergoline side effect was reported by a Physician from on Apr 15, 2005. Male patient, 74 years of age, weighting 112.0 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea exertional, pericardial effusion, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with SENNA LEAF, HERBAL PREPARATION. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4617892-3
Cabergoline side effect was reported by a Physician from on Mar 09, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, cardiac failure, dyskinesia, dyspnoea exertional, oedema peripheral, pleural effusion, weight increased. Cabergoline dosage: 2 MG, ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4645346-7
Cabergoline side effect was reported by a Physician from on Apr 11, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, aortic valve incompetence, blood pressure systolic increased, cardiac failure, cardiomegaly, dilatation atrial, dyspnoea exertional, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 2 MG , ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4931079-6
Cabergoline side effect was reported by a Physician from GERMANY on Feb 13, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.

Cabergoline Side Effects Report #4960888-2
Cabergoline side effect was reported by a Physician from GERMANY on Mar 14, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic dilatation, aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.

Cabergoline Side Effects Report #4886851-8
Cabergoline side effect was reported by a Physician from GERMANY on Jan 09, 2006. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea exertional. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4753569-1
Cabergoline side effect was reported by a Physician from GERMANY on Aug 15, 2005. Female patient, 67 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, atrial flutter, dyspnoea, dyspnoea at rest, dyspnoea exertional, inflammation, pericarditis constrictive, pleural effusion. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, COMTESS, AMANTADINE, NACOM, EDRONAX. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #5154439-X
Cabergoline side effect was reported by a Physician from GERMANY on Nov 02, 2006. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 12 MG, ORAL. During the same period patient was treated with COMTESS, SINEMET. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #5484537-2
Cabergoline side effect was reported by a Physician from GERMANY on Oct 02, 2007. Female patient, 55 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dyspnoea exertional. Cabergoline dosage: DAILY DOSE:4MG. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5603010-1
Cabergoline side effect was reported by a Physician from AUSTRALIA on Jan 15, 2008. Male patient, weighting 187.4 lb, was diagnosed with parkinson's disease , restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bronchial disorder, coronary artery bypass , dyspnoea exertional, fibrosis, lung consolidation, pleural effusion, restless legs syndrome. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, SINEMET CR, KARVEA, VITAMIN E, TRITACE, ZOCOR. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5685104-8
Cabergoline side effect was reported by a Health Professional from AUSTRALIA on Mar 18, 2008. Female patient, weighting 154.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: chest pain , decreased appetite, dyspnoea exertional, pleural fibrosis, pneumonitis, weight decreased. Cabergoline dosage: unknown. During the same period patient was treated with COMTAN, LEXAPRO, DOMPERIDONE, SINEMET, SINEMET CR, TEMAZEPAM. Patient recovered.

Cabergoline Side Effects Report #4575789-1
Cabergoline side effect was reported by a Physician from on Jan 24, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure increased, dyspnoea, dyspnoea exertional, face oedema, histology abnormal, mitral valve disease, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR, ACETYLSALICYLIC ACID SRT, ZUMESTON. Patient recovered.